Fri November 3, 2017
AIDS Survivor Syndrome: New data from the Multi-Center AIDS Cohort Study and Voices of Survivors Themselves
SEE EVENT DETAILS
Let's Kick ASS Presents a free, lunchtime town hall for providers and community with lunch provided.
Since coining the term "AIDS Survivor Syndrome" we've received hundreds of messages and emails from people who felt supported by the knowledge that 1.) they were not crazy and 2.) not the only ones experiencing something they did not understand and couldn't name. But we’ve needed research data to confirm the existence and impact of AIDS Survivor Syndrome (ASS).Now we have it Ron Stall Ph.D., M.P.H., Director of the Center for LGBT Health Research and Associate Chair for Science Dept. of Behavioral and Community Health Sciences at the Graduate School of Public Health at the University of Pittsburgh has conducted a study using the Multi-Center AIDS Cohort Study (MACS) data. Dr. Stall as he presents his findings at an event entitled, Research on the AIDS Survivor Syndrome: New data from the Multi-Center AIDS Cohort Study and Voices of Survivors Themselves. The event is both providers and community. It's on Friday, November 3, 2017, starting at noon. Doors open at 11:30 AM and lunch will be provided, courtesy of Nopo Pharmaceuticals, makers of Mytesi®, approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.In addition to Dr. Stall presenting his findings, we'll hear from HIV Long-Term Survivors some of those empowering messages.Dr. Stall began working in HIV research in 1984 when he started working with the AIDS Behavioral Research Project, one of the first longitudinal studies of AIDS risk-taking behaviors in the world. Since that time, he has published over 190 peer-reviewed scientific papers on many different aspects of the AIDS epidemic. Recently, Dr. Stall has become interested in the combined effects of multiple psychosocial epidemics, or “syndemics” in driving HIV risk. Ron is also "working with a group of very smart colleagues to propose a theory of resilience among gay men, and to propose a research agenda to study strengths among gay men." Something HIV Long-Term Survivors exhibit daily and for decades.Among his many gifts is putting scientific data into plain language makes it easier for everyone to understand and use health information. Plain language is a goal Let's Kick ASS also ascribes. We are thrilled to welcome Dr. Stall as he explains the findings on AIDS Survivor Syndrome.
show less
Since coining the term "AIDS Survivor Syndrome" we've received hundreds of messages and emails from people who felt supported by the knowledge that 1.) they were not crazy and 2.) not the only ones experiencing something they did not understand and couldn't name. But we’ve needed research data to confirm the existence and impact of AIDS Survivor Syndrome (ASS).Now we have it Ron Stall Ph.D., M.P.H., Director of the Center for LGBT Health Research and Associate Chair for Science Dept. of Behavioral and Community Health Sciences at the Graduate School of Public Health at the University of Pittsburgh has conducted a study using the Multi-Center AIDS Cohort Study (MACS) data. Dr. Stall as he presents his findings at an event entitled, Research on the AIDS Survivor Syndrome: New data from the Multi-Center AIDS Cohort Study and Voices of Survivors Themselves. The event is both providers and community. It's on Friday, November 3, 2017, starting at noon. Doors open at 11:30 AM and lunch will be provided, courtesy of Nopo Pharmaceuticals, makers of Mytesi®, approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.In addition to Dr. Stall presenting his findings, we'll hear from HIV Long-Term Survivors some of those empowering messages.Dr. Stall began working in HIV research in 1984 when he started working with the AIDS Behavioral Research Project, one of the first longitudinal studies of AIDS risk-taking behaviors in the world. Since that time, he has published over 190 peer-reviewed scientific papers on many different aspects of the AIDS epidemic. Recently, Dr. Stall has become interested in the combined effects of multiple psychosocial epidemics, or “syndemics” in driving HIV risk. Ron is also "working with a group of very smart colleagues to propose a theory of resilience among gay men, and to propose a research agenda to study strengths among gay men." Something HIV Long-Term Survivors exhibit daily and for decades.Among his many gifts is putting scientific data into plain language makes it easier for everyone to understand and use health information. Plain language is a goal Let's Kick ASS also ascribes. We are thrilled to welcome Dr. Stall as he explains the findings on AIDS Survivor Syndrome.
Let's Kick ASS Presents a free, lunchtime town hall for providers and community with lunch provided.
Since coining the term "AIDS Survivor Syndrome" we've received hundreds of messages and emails from people who felt supported by the knowledge that 1.) they were not crazy and 2.) not the only ones experiencing something they did not understand and couldn't name. But we’ve needed research data to confirm the existence and impact of AIDS Survivor Syndrome (ASS).Now we have it Ron Stall Ph.D., M.P.H., Director of the Center for LGBT Health Research and Associate Chair for Science Dept. of Behavioral and Community Health Sciences at the Graduate School of Public Health at the University of Pittsburgh has conducted a study using the Multi-Center AIDS Cohort Study (MACS) data. Dr. Stall as he presents his findings at an event entitled, Research on the AIDS Survivor Syndrome: New data from the Multi-Center AIDS Cohort Study and Voices of Survivors Themselves. The event is both providers and community. It's on Friday, November 3, 2017, starting at noon. Doors open at 11:30 AM and lunch will be provided, courtesy of Nopo Pharmaceuticals, makers of Mytesi®, approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.In addition to Dr. Stall presenting his findings, we'll hear from HIV Long-Term Survivors some of those empowering messages.Dr. Stall began working in HIV research in 1984 when he started working with the AIDS Behavioral Research Project, one of the first longitudinal studies of AIDS risk-taking behaviors in the world. Since that time, he has published over 190 peer-reviewed scientific papers on many different aspects of the AIDS epidemic. Recently, Dr. Stall has become interested in the combined effects of multiple psychosocial epidemics, or “syndemics” in driving HIV risk. Ron is also "working with a group of very smart colleagues to propose a theory of resilience among gay men, and to propose a research agenda to study strengths among gay men." Something HIV Long-Term Survivors exhibit daily and for decades.Among his many gifts is putting scientific data into plain language makes it easier for everyone to understand and use health information. Plain language is a goal Let's Kick ASS also ascribes. We are thrilled to welcome Dr. Stall as he explains the findings on AIDS Survivor Syndrome.
read more
Since coining the term "AIDS Survivor Syndrome" we've received hundreds of messages and emails from people who felt supported by the knowledge that 1.) they were not crazy and 2.) not the only ones experiencing something they did not understand and couldn't name. But we’ve needed research data to confirm the existence and impact of AIDS Survivor Syndrome (ASS).Now we have it Ron Stall Ph.D., M.P.H., Director of the Center for LGBT Health Research and Associate Chair for Science Dept. of Behavioral and Community Health Sciences at the Graduate School of Public Health at the University of Pittsburgh has conducted a study using the Multi-Center AIDS Cohort Study (MACS) data. Dr. Stall as he presents his findings at an event entitled, Research on the AIDS Survivor Syndrome: New data from the Multi-Center AIDS Cohort Study and Voices of Survivors Themselves. The event is both providers and community. It's on Friday, November 3, 2017, starting at noon. Doors open at 11:30 AM and lunch will be provided, courtesy of Nopo Pharmaceuticals, makers of Mytesi®, approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.In addition to Dr. Stall presenting his findings, we'll hear from HIV Long-Term Survivors some of those empowering messages.Dr. Stall began working in HIV research in 1984 when he started working with the AIDS Behavioral Research Project, one of the first longitudinal studies of AIDS risk-taking behaviors in the world. Since that time, he has published over 190 peer-reviewed scientific papers on many different aspects of the AIDS epidemic. Recently, Dr. Stall has become interested in the combined effects of multiple psychosocial epidemics, or “syndemics” in driving HIV risk. Ron is also "working with a group of very smart colleagues to propose a theory of resilience among gay men, and to propose a research agenda to study strengths among gay men." Something HIV Long-Term Survivors exhibit daily and for decades.Among his many gifts is putting scientific data into plain language makes it easier for everyone to understand and use health information. Plain language is a goal Let's Kick ASS also ascribes. We are thrilled to welcome Dr. Stall as he explains the findings on AIDS Survivor Syndrome.
show less
Date/Times:
The San Francisco LGBT Center
3 Upcoming Events
1800 Market Street, San Francisco, CA 94102
The Best Events
Every Week in Your Inbox
From Our Sponsors
UPCOMING EVENTS
Great suggestion! We'll be in touch.
Event reviewed successfully.